Real-World study tracks CLL patients on acalabrutinib
NCT ID NCT05645172
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study watches 137 adults with chronic lymphocytic leukemia (CLL) who are already prescribed acalabrutinib by their doctors. Researchers will track how many patients are still taking the drug after 1 and 2 years. No new treatments or changes are made—just observation of real-world use in Germany.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
D Ren, Germany, 52353, Germany
-
Research Site
Herrsching am Ammersee, Germany, 82211, Germany
-
Research Site
L Rrach, Germany, 79539, Germany
-
Research Site
M Nchen, Germany, 80804, Germany
-
Research Site
M Nchen, Germany, 81377, Germany
-
Research Site
N Rnberg, Germany, 90449, Germany
-
Research Site
Neustadt Am R Benberge, Germany, 31535, Germany
-
Research Site
Saarbr Cken, Germany, 66113, Germany
-
Research Site
Sindelfinden, Germany, 71065, Germany
-
Research Site
W Rselen, Germany, 52146, Germany
-
Research Site
Amberg, 92224, Germany
-
Research Site
Aschaffenburg, 63739, Germany
-
Research Site
Augsburg, 86150, Germany
-
Research Site
Bad Homburg, 61352, Germany
-
Research Site
Bad Liebenwerda, 04924, Germany
-
Research Site
Bautzen, 02625, Germany
-
Research Site
Berlin, 10117, Germany
-
Research Site
Berlin, 13055, Germany
-
Research Site
Berlin, 13156, Germany
-
Research Site
Bonn, 53115, Germany
-
Research Site
Dachau, 85221, Germany
-
Research Site
Delitzsch, 04509, Germany
-
Research Site
Dessau, 06487, Germany
-
Research Site
Dortmund, 44263, Germany
-
Research Site
Erfurt, 99084, Germany
-
Research Site
Erfurt, 99085, Germany
-
Research Site
Essen, 45136, Germany
-
Research Site
Frankfurt am Main, 60596, Germany
-
Research Site
Frankfurt am Main, 65929, Germany
-
Research Site
Garbsen, 30823, Germany
-
Research Site
Halle, 06110, Germany
-
Research Site
Hanover, 30161, Germany
-
Research Site
Hanover, 30625, Germany
-
Research Site
Heide, 25746, Germany
-
Research Site
Herten, 45699, Germany
-
Research Site
Hof, 04509, Germany
-
Research Site
Kulmbach, 95326, Germany
-
Research Site
Laatzen, 30880, Germany
-
Research Site
Landshut, 72764, Germany
-
Research Site
Lebach, 66822, Germany
-
Research Site
Leipzig, 04103, Germany
-
Research Site
Leipzig, 04289, Germany
-
Research Site
Moers, 47441, Germany
-
Research Site
Naunhof, 04683, Germany
-
Research Site
Oldenburg, 26121, Germany
-
Research Site
Paderborn, 33098, Germany
-
Research Site
Pasing, 81281, Germany
-
Research Site
Pirna, 01796, Germany
-
Research Site
Porta Westfalica, 32457, Germany
-
Research Site
Potsdam, 14482, Germany
-
Research Site
Remscheid, 42859, Germany
-
Research Site
Reutlingen, 72764, Germany
-
Research Site
Riesa, 01589, Germany
-
Research Site
Saalfeld, 07318, Germany
-
Research Site
Schkeuditz, 04435, Germany
-
Research Site
Schorndorf, 73614, Germany
-
Research Site
Siegburg, 53721, Germany
-
Research Site
Straubing, 94315, Germany
-
Research Site
Twistringen, 27239, Germany
-
Research Site
Weiden, 92637, Germany
-
Research Site
Zittau, '02763, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.